Lab Corp. (LH) Tops Q2 EPS by 54c; Raises Outlook

Lab Corp. (NYSE: LH) reported Q2 EPS of $6.13, $0.54 better than the analyst estimate of $5.59. Revenue for the quarter came in at $3.8 billion versus the consensus estimate of $3.62 billion.

GUIDANCE:

Lab Corp. sees FY2021 EPS of $21.50-$25.00, versus the consensus of $22.54. Revenue raised to range of 6.5% to 9.0. Free Cash Flow raised to range of $1.95 billion to $2.15 billion.

For earnings history and earnings-related data on Lab Corp. (LH) click here.

You May Also Be Interested In

• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
• LEEF Brands appoints Hirsh Jain to board as independent director
• Rubico to shift from semi-annual to quarterly financial reporting